▲ BUY
5
/ 10
Conviction
$ Value
—
Shares
29,415
Price
—
Filed
Aug 13
▶ Why this score? (5/10)
- ✓ Open market buy (+3)
- ✓ Director (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Baluch Khoso
Title
—
CIK
0001686223
Roles
Director
Transaction Details
Transaction Date
2025-08-11
Code
P
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
29,415
Footnotes
The combined purchase price for each share of Class A Common Stock and accompanying two and one-half Class A Common Warrants was $0.85.
Filing Info
Baluch Khoso's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-31 | PCSA | ▲ | $6K ★ |
| 2025-10-01 | PCSA | A | $0 |
| 2025-10-01 | PCSA | A | $0 |
| 2025-08-11 | LGVN | ▲ | — |
| 2025-08-11 | LGVN | ▲ | — |
| 2025-07-24 | PCSA | A | $0 |
| 2025-07-15 | LGVN | A | $0 |
| 2024-09-03 | PCSA | A | $0 |
Other Insiders at LGVN (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Willard Stephen H
Chief Executive Officer
|
— | — | 2026-04-01 |
|
Lehr Paul T
General Counsel, Secretary
|
— | — | 2026-04-01 |
|
Agafonova Nataliya
Chief Medical Officer
|
— | — | 2026-04-01 |
|
Locklear Lisa
Chief Financial Officer
|
— | — | 2026-04-01 |
|
Blass Devin
CTO & SVP of CMC
|
— | — | 2026-04-01 |